
CYP2C19 Metaboliser Status Linked to DNA Methylation Patterns
TL;DR: A 2026 methylome-wide study in Clinical Epigenetics found that genetically inferred CYP2C19 metaboliser status, a pharmacogenomic marker relevant to antidepressant handling, was associated with DNA methylation patterns in a large Scottish cohort. Key Fi…
Read article
